This article is more than 5 years old. Information may no longer be current.

VIDEO: New glaucoma medications target trabecular meshwork to lower IOP

Issue: December 10, 2017

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

NEW YORK — At OSN New York 2017, Robert J. Noecker, MD, MBA, gives an overview of the latest glaucoma therapies that work in the trabecular meshwork and are undergoing clinical trials. He said it is becoming more important to consider not only the pressure lowering of drops but also the method by which they lower IOP.